Shanghai Kindly Medical Instruments Co., Ltd. Announces First Patient Implantation of Hanchorvalve Clinical Trial
November 24, 2021 at 05:20 am IST
Share
Shanghai Kindly Medical Instruments Co., Ltd. announced that the first patient implantation of HanchorValve, a balloon-expandable transcatheter aortic valve replacement product with an anchoring structure developed by Shanghai Healing Medical Instruments Co., Ltd, a subsidiary of the Company, has been successfully completed by Zhongshan Hospital, Fudan University, which is also the first valve replacement operation that uses the balloon-expandable TAVR product with an anchoring structure to treat patient with severe aortic regurgitation in the world. HanchorValve is the first TAVR product that Healing Medical has self-owned intellectual property rights, which is able to achieve precise and autonomous localization by virtue of its unique design of anchoring structure. It is also the first balloon-expandable TAVR product in the world that can treat both severe aortic regurgitation and severe aortic stenosis by transfemoral approach. The success achieved in the first patient implantation of HanchorValve clinical trial marks the official launch of national multi-center clinical trial with Zhongshan Hospital, Fudan University as the major research center.
Shanghai INT Medical Instruments Co Ltd, formerly Shanghai Kindly Medical Instruments Co Ltd, is a China-based company principally engaged in the research, development, production and sales of intracardiac interventional devices. The Company operates its businesses through two segments. The Intracardiac Interventional Business segment is mainly engaged in the sales, manufacturing and research and development of intracardiac interventional medical devices and related molds, standard parts and masks. The Other segment is engaged in the research and development of other interventional medical devices, such as neurointerventional medical devices and heart valve implantable medical devices. The Company mainly operates its businesses in the domestic market and overseas markets.